Company profile XOMA

XOMA Corp
xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partne...rs and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com. Show More
Quarter analysis & expected interest

There is not enough data for XOMA near me to provide analysis

Correlation between past revenue and XOMA near me search interest

There is not enough data for XOMA near me to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA near me to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:17:47.

After 39 days of this quarter the interest is at 88.0. Based on that we can calculate that during remaining 52 days it will total up to 205.0.
XOMA stock price expected interest is significantly higher compared to same quarter last year (+105.0%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019107
121
13.1% QoQ
149
23.1% QoQ
51
-65.8% QoQ
2020 101
-5.6% YoY 98.0% QoQ
82
-32.2% YoY -18.8% QoQ
88
-40.9% YoY 7.3% QoQ
83
62.7% YoY -5.7% QoQ
2021 126
24.8% YoY 51.8% QoQ
159
93.9% YoY 26.2% QoQ
112
27.3% YoY -29.6% QoQ
65
-21.7% YoY -42.0% QoQ
2022 110
-12.7% YoY 69.2% QoQ
46
-71.1% YoY -58.2% QoQ
101
-9.8% YoY 119.6% QoQ
69
6.2% YoY -31.7% QoQ
2023 100
-9.1% YoY 44.9% QoQ
60
30.4% YoY -40.0% QoQ
41
-59.4% YoY -31.7% QoQ
184
166.7% YoY 348.8% QoQ
2024 88
-12.0% YoY -52.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and XOMA stock price search interestLast update: February 09 2024 10:17:46.
Correlation coefficient between keyword and revenue is -0.17
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:17:48.

The average 5 years interest of XOMA stock price was 7.83 per week.
The last year interest of XOMA stock price compared to the last 5 years has changed by 4.85%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -13.58%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 10:17:56.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
XOMA news expected interest is significantly lower compared to previous quarter (-100.0%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201930
101
236.7% QoQ
24
-76.2% QoQ
90
275.0% QoQ
2020 153
410.0% YoY 70.0% QoQ
71
-29.7% YoY -53.6% QoQ
16
-33.3% YoY -77.5% QoQ
0
-100.0% YoY -100.0% QoQ
2021 104
-32.0% YoY inf% QoQ
101
42.3% YoY -2.9% QoQ
47
193.8% YoY -53.5% QoQ
83
inf% YoY 76.6% QoQ
2022 61
-41.3% YoY -26.5% QoQ
152
50.5% YoY 149.2% QoQ
71
51.1% YoY -53.3% QoQ
38
-54.2% YoY -46.5% QoQ
2023 0
-100.0% YoY -100.0% QoQ
15
-90.1% YoY inf% QoQ
24
-66.2% YoY 60.0% QoQ
129
239.5% YoY 437.5% QoQ
2024 0
239.5% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and XOMA news search interestLast update: February 09 2024 10:17:55.
Correlation coefficient between keyword and revenue is -0.21
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 10:17:57.

The average 5 years interest of XOMA news was 5.02 per week.
The last year interest of XOMA news compared to the last 5 years has changed by -35.66%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -40.19%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA pipeline to provide analysis

Correlation between past revenue and XOMA pipeline search interest

There is not enough data for XOMA pipeline to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA pipeline to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA healthcare to provide analysis

Correlation between past revenue and XOMA healthcare search interest

There is not enough data for XOMA healthcare to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA healthcare to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA biotechnology to provide analysis

Correlation between past revenue and XOMA biotechnology search interest

There is not enough data for XOMA biotechnology to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA biotechnology to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA clinical assets to provide analysis

Correlation between past revenue and XOMA clinical assets search interest

There is not enough data for XOMA clinical assets to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA clinical assets to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA royalty aggregator to provide analysis

Correlation between past revenue and XOMA royalty aggregator search interest

There is not enough data for XOMA royalty aggregator to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA royalty aggregator to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA pharmaceutical companies to provide analysis

Correlation between past revenue and XOMA pharmaceutical companies search interest

There is not enough data for XOMA pharmaceutical companies to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA pharmaceutical companies to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for XOMA Emeryville to provide analysis

Correlation between past revenue and XOMA Emeryville search interest

There is not enough data for XOMA Emeryville to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for XOMA Emeryville to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for XOMA
Earnings date: 2024-03-06 After close
Company name: XOMA Corp
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-14T17:25:00-04:00

PR Newswire
Are XOMA, OGN, VRE Obtaining Fair Deals for their Shareholders?

2026-05-08T17:57:00-04:00

PR Newswire
Are SEM, XOMA, SLNO, KORE Obtaining Fair Deals for their Shareholders?

2026-05-06T14:27:00-04:00

PR Newswire
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--HLX, OGN, XOMA, and RMAX

2026-05-04T14:55:00-04:00

PR Newswire
Are XOMA, RMAX, KALV Obtaining Fair Deals for their Shareholders?

2026-04-30T16:15:06Z

Analyst Upgrades
This Appian Analyst Is No Longer Bullish; Here Are Top 2 Downgrades For Thursday

2026-04-30T10:40:10Z

Analyst Upgrades
HC Wainwright & Co. Downgrades XOMA Royalty to Neutral, Announces $39 Price Target

2026-04-27T15:06:00-04:00

PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of XOMA Royalty Corporation

2026-04-27T11:24:00-04:00

PR Newswire
Are OGN, RMAX, XOMA, REAX Obtaining Fair Deals for their Shareholders?

2026-04-27T10:00:00-04:00

PR Newswire
Shareholder Alert: Ademi LLP investigates whether XOMA Royalty Corporation is obtaining a Fair Price for Public Shareholders

2026-04-27T11:00:00Z

GlobeNewswire
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand's Position as a Leading Biopharma Royalty Aggregator

2026-03-20T10:30:57Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on XOMA Royalty, Maintains $97 Price Target

2026-02-24T20:20:55Z

Analyst Upgrades
Leerink Partners Maintains Outperform on XOMA Royalty, Raises Price Target to $50

2026-02-18T21:30:00Z

GlobeNewswire
XOMA Royalty to Present at Investor Conferences in March

2026-02-09T14:53:00Z

GlobeNewswire
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.

2026-01-22T10:00:00-05:00

PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA